What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
His primary areas of study are Alzheimer's disease, Atrophy, Pathology, Dementia and Disease.
His Alzheimer's disease research is multidisciplinary, incorporating elements of Apolipoprotein E, Magnetic resonance imaging, Genome-wide association study and Degenerative disease.
His study focuses on the intersection of Atrophy and fields such as Temporal lobe with connections in the field of Frontal lobe.
Nick C. Fox has researched Pathology in several fields, including White matter and Gene mutation.
His work focuses on many connections between Dementia and other disciplines, such as Pediatrics, that overlap with his field of interest in Mini–Mental State Examination.
His Disease research incorporates elements of Clinical trial, Psychiatry, Cognition, Neuroscience and Biomarker.
His most cited work include:
- The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. (2619 citations)
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2614 citations)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2556 citations)
What are the main themes of his work throughout his whole career to date?
Nick C. Fox mainly investigates Pathology, Atrophy, Disease, Dementia and Alzheimer's disease.
His Pathology study frequently links to other fields, such as Temporal lobe.
Nick C. Fox has included themes like Magnetic resonance imaging, Central nervous system disease and Nuclear medicine in his Atrophy study.
His studies deal with areas such as Biomarker, Cognition, Neuroscience and Clinical trial as well as Disease.
His work deals with themes such as Psychiatry, Neurology, Pediatrics and Neuropsychology, which intersect with Dementia.
His research is interdisciplinary, bridging the disciplines of Apolipoprotein E and Alzheimer's disease.
He most often published in these fields:
- Pathology (31.64%)
- Atrophy (29.97%)
- Disease (26.44%)
What were the highlights of his more recent work (between 2017-2021)?
- Disease (26.44%)
- Dementia (23.11%)
- Internal medicine (16.94%)
In recent papers he was focusing on the following fields of study:
Nick C. Fox mainly focuses on Disease, Dementia, Internal medicine, Pathology and Cognition.
His Disease study incorporates themes from Neuroimaging and Neuroscience.
His Neuroscience study frequently draws connections to adjacent fields such as Atrophy.
His work investigates the relationship between Dementia and topics such as Alzheimer's disease that intersect with problems in Asymptomatic and Pediatrics.
His Internal medicine research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Oncology and Cardiology.
He combines subjects such as Basal ganglia and Blood pressure with his study of Pathology.
Between 2017 and 2021, his most popular works were:
- Analysis of shared heritability in common disorders of the brain (726 citations)
- Analysis of shared heritability in common disorders of the brain (726 citations)
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. (303 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
His scientific interests lie mostly in Disease, Dementia, Internal medicine, Alzheimer's disease and Frontotemporal dementia.
The study incorporates disciplines such as Longitudinal study and Gerontology in addition to Disease.
Pathology covers Nick C. Fox research in Dementia.
Nick C. Fox interconnects Young adult and Blood pressure in the investigation of issues within Pathology.
His biological study spans a wide range of topics, including Magnetic resonance imaging, Oncology and Cardiology.
His Alzheimer's disease research is multidisciplinary, relying on both Amino acid, In vitro, Asymptomatic and Cognition.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
